BermanS. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis1991; 13:s454–62
2.
FiebachNBeckettW. Prevention of respiratory infections in adults. Arch Intern Med1994; 154: 2545–57
3.
RileyIDDouglasRM. An epidemiologic approach to pneumococcal disease. Rev Infect Dis1981; 3: 233–45
4.
KleinJO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis1981; 3: 246–53
5.
GilksCFOjooSAOjooJC. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet1995; 346: 1034–5
6.
HirschtickREGlassrothJJordanMC. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med1995; 333: 845–51
7.
PaulJKimariJGilksCF. Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity [Letter]. Lancet1995; 346: 1034–5
8.
HenrichsenJ. Six newly recognised types of Streptococcus pneumoniae. J Clin Microbiol1995; 33: 2759–62
9.
ScottJAGHallAJDaganR. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex and geography in 7000 episodes of invasive disease. Clin Infect Dis1996; 22: 973–81
10.
HedlundJ. Should pneumococcal infections continue to be classified as a single disease?Lancet; 1998; 349: 371–2
11.
KlugmanKPFriedlandIRBradleyJS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother1995; 39: 1988–92
12.
KlugmanKPKoornhofHJ. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979–1986. J Infect Dis1988; 158: 956–64
13.
KoornhofHJWasasAKlugmanK. Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin Infect Dis1992; 15: 84–94
KeuschGT. Nutritional effects on response of children in developing countries to respiratory tract pathogens: implications for vaccine development. Rev Infect Dis1991; 13:s486–91
16.
GreenwoodBMHassan-KingMOnyemelukweG. Pneumococcal serotypes in West Africa [Letter]. Lancet1980; i: 360
17.
DenisFAGreenwoodBDReyJL. Multicenter study of pneumococcal serotypes in Africa. Bull World Health Org1983; 61: 661–9
18.
BogaertsJLepagePTaelmanH. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984–1990. J Infect1993; 27: 157–68
19.
GilksCF. Pneumococcal disease and HIV infection (Letter). Ann Int Med1993; 118: 393
20.
JordensJZPaulJBatesJBeaumontCKimariJGilksC. Characterization of Streptococcus pneumoniae from human immunodeficiency virus — seropositive patients with acute and recurrent pneumonia. J Infect Dis1995; 172: 983–7
21.
PaulJBatesJKimariJGilksC. Serotypes and antibiotic susceptibilities of Streptococcus pneumoniae in Nairobi, Kenya. J Infect1996; 32: 139–42
22.
HervaELuotonenJTimonenMSibakovMKarmaPMakelaPH. The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae. Scand J Infect Dis1980; 12: 97–100
